Brian Powl
Chief Commercial OfficeratKura Oncology· In the 2025 proxy
Pay in FY2025Kura Oncology stock +19.3% the same year
Brian Powl was paid $2.7M in FY2025 (Dec). Kura Oncology stock rose 19.3% that year.
Pay$100 in the stock at the end of FY24 → $119
Experience
- Kura OncologyPublic company · 1 yr
- Chief Commercial Officer2025 – Present · 1 yrStock in role +21%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?